Oil and drugs barons lead the dollar romp
Chevron and AstraZeneca led a dash for dollars this week as issuers made the most of favourable funding conditions in what is expected to be a heavy month for high grade supply.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: